In some other types of cancer with a high frequency of SPOP mutation, such as prostate and endometrial cancers with 8–14% rate of SPOP mutation, little is known about how SPOP mutations influence the stability of its substrates. This evidence concerns the gene SPOP and endometrial cancer.